Results 51 to 60 of about 241,804 (118)

Head-to-head comparison of ^99mTc-PSMA and ^99mTc-MDP SPECT/CT in diagnosing prostate cancer bone metastasis: a prospective, comparative imaging trial. [PDF]

Sci Rep, 2022
Zhang Y, Lin Z, Li T, Wei Y, Yu M, Ye L, Cai Y, Yang S, Zhang Y, Shi Y, Chen W.   +10 more
europepmc   +1 more source

^99m Tc bone scintigraphy does not affect preoperative workup for patients with potentially resectable esophageal squamous cell carcinoma. [PDF]

Thorac Cancer, 2022
Wei XF, Chen XK, Lu L, Luo P, Xu L, Xie HN, Yang YF, Yu YK, Li HM, Liu Q, Zhang RX, Qin JJ, Li Y.   +12 more
europepmc   +1 more source

Technetiumm-99m-N,N-ethylenedicysteine scintigraphy in the detection of renal parenchymal abnormalities: A comparative study with Tc-99m DMSA

, 1997
Purpose: Technetium-99m dimercaptosuccinic acid (Tc-99m DMSA) is currently the most important agent in the detection of renal parenchymal defect, and allows calculation of differential renal function (DRF). But this agent has some important disadvantages
Kibar M., Reyhan M., Paydas S., Noyan A., Anarat A., Tutus A., Yurdakul G.   +6 more
core   +1 more source

Trends in coordination of rhenium organometallic complexes in the Protein Data Bank. [PDF]

IUCrJ, 2022
Brink A, Jacobs FJF, Helliwell JR.
europepmc   +1 more source

Comparison of Bone Metastases between ¹⁸F-NaF PET/CT, ¹⁸F-NaF PET, and Planar ^99mTc-MDP Bone Scintigraphy in Patients with Newly Diagnosed Nasopharyngeal Carcinoma. [PDF]

Contrast Media Mol Imaging, 2022
Wang D, Yang Y, Zeng Z, Ye J, Guo C, Huang S, Guo X, Xiao J.   +7 more
europepmc   +1 more source

The Scientific and Clinical Case for Reviewing Diagnostic Radiopharmaceutical Extravasation Long-Standing Assumptions. [PDF]

Front Med (Lausanne), 2021
Osborne D, Lattanze R, Knowland J, Bryant TE, Barvi I, Fu Y, Kiser JW.   +6 more
europepmc   +1 more source

Bone Tracers for Transthyretin Amyloid Cardiomyopathy: Are [^99mTc]Tc-DPD and [^99mTc]Tc-HMDP Equivalent? [PDF]

Mol Imaging
Dubois J, Kucharczak F, Mariano-Goulart D, Paunet T.   +3 more
europepmc   +1 more source

Technetium-99m-labeled HL91 to identify tumor hypoxia: Correlation with fluorine-18-FDG

, 1998
Technetium-99m HL91 is a potential agent for imaging hypoxic tissue in vivo. A pilot evaluation using a prototype formulation assessed efficacy in tumor imaging and compared results with F-18-fluorodeoxyglucose (FDG) PET, Methods: Ten patients with ...
Cook, G. J. R.; id_orcid, Fogelman, I., Houston, S., Barrington, S. F.; id_orcid   +3 more
core   +1 more source

Direct comparison uptake patterns of ^99mTc-PYP and ^99mTc-HMDP scintigraphy in cardiac amyloidosis with semi-quantitative analysis. [PDF]

Jpn J Radiol
Ensako T, Norikane T, Yamamoto Y, Takami Y, Manabe Y, Murao M, Imajo M, Mitamura K, Omori K, Oishi A, Morimoto M, Noma T, Nishiyama Y.   +12 more
europepmc   +1 more source

The performance of ⁶⁸Ga-DOTA-IBA PET/CT for detecting bone metastases compared with ^99mTc-MDP bone scintigraphy. [PDF]

Sci Rep
Lin X, Zhang N, Wang R, Liu H, Wang W, Xu T, Chen Y.   +6 more
europepmc   +1 more source